Technology Assessment in a User Perspective-Experiences with Drug Technology

Author:

Hansen Ebba Holme

Abstract

AbstractDrugs have a central place among medical technologies, and medical technology assessment can learn from the established regulation of drug technology. This article outlines how users' experiences are not part of the basis on which decisions are made today, although this knowledge is imperative for identifying the problems that are not uncovered or foreseen by today's drug assessments. Further, users' interests might not be part of assessments that are based on the controlled clinical trial. A framework for drug technology assessments based on a user perspective is suggested.

Publisher

Cambridge University Press (CUP)

Subject

Health Policy

Reference64 articles.

1. Pitfalls and prospects in clinical research on antianxiety drugs: Benzodiazepines and placebo — A research review;Solomon;The Journal of Clinical Psychiatry,1978

2. Drugs and users—problems and new directions

3. Forsøgs-patienter informeres dårligt (Trial-patients are badly informed);Scocozza;Sygeplejersken,1990

4. Rationality and common sense in Danish drug therapy;Hansen;Journal of Social and Administrative Pharmacy,1988

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3